Bronfeld Zeev 4/A
4/A · ORAMED PHARMACEUTICALS INC. · Filed Oct 5, 2011
Insider Transaction Report
Form 4/AAmended
ORAMED PHARMACEUTICALS INC.ORMP.OB
Bronfeld Zeev
10% Owner
Transactions
- Sale
Common Stock
2011-09-27$0.28/sh−350,000$98,000→ 5,808,517 total
Holdings
- 781,250(indirect: Via DNA Biomedical Solutions Ltd.)
Common Stock
Footnotes (1)
- [F1]D.N.A Biomedical Solutions Ltd. ("DNA") owns 781,250 shares of common stock of the Issuer ("Common Stock") and warrants exercisable for 273,438 shares of Common Stock. The Reporting Person holds 22.13% of DNA's outstanding share capital. The Reporting Person and Mr. Meni Mor are parties to a Voting Agreement relating to their shares of DNA, representing, in the aggregate, approximately 44.36% of DNA's outstanding share capital. As a result of the Voting Agreement, the Reporting Person may be deemed a beneficial owner of, and to share the power to vote and dispose, the Issuer securities held by DNA. The Reporting Person disclaims beneficial ownership of any of the Issuer securities held by DNA. The Form 4 is being amended to correct the percentages of DNA outstanding share capital owed by the Reporting Person and Mr. Mor referenced in this footnote.